Cargando…

Impact of PET/CT for Assessing Response to Immunotherapy—A Clinical Perspective

Cancer immunotherapy using immune-checkpoint inhibitors (ICI) has revolutionized the therapeutic landscape of various malignancies like non-small-cell lung cancer or melanoma. Pre-therapy response prediction and assessment during ICI treatment is challenging due to the lack of reliable biomarkers an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lang, David, Wahl, Gerald, Poier, Nikolaus, Graf, Sebastian, Kiesl, David, Lamprecht, Bernd, Gabriel, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7694130/ https://www.ncbi.nlm.nih.gov/pubmed/33126715 http://dx.doi.org/10.3390/jcm9113483

Ejemplares similares

MRI and PET/CT in the assessment of lymph node metastases in head and neck cancer
por: Zwittag, Paul, et al.
Publicado: (2023)

PET/CT and the Response to Immunotherapy in Lung Cancer
por: Evangelista, Laura, et al.
Publicado: (2020)

PET/CT imaging for tumour response assessment to immunotherapy: current status and future directions
por: Unterrainer, Marcus, et al.
Publicado: (2020)

Response evaluation after immunotherapy in NSCLC: Early response assessment using FDG PET/CT
por: Park, Sohyun, et al.
Publicado: (2020)

Adapting Imaging Protocols for PET-CT and PET-MRI for Immunotherapy Monitoring
por: Beuthien-Baumann, Bettina, et al.
Publicado: (2021)

PET/CT in Oncology: Current Status and Perspectives
por: Czernin, Johannes, et al.
Publicado: (2013)

(68)Ga-DOTATATE PET/CT and MRI with Diffusion-Weighted Imaging (DWI) in Short- and Long-Term Assessment of Tumor Response of Neuroendocrine Liver Metastases (NELM) Following Transarterial Radioembolization (TARE)
por: Ingenerf, Maria, et al.
Publicado: (2021)

Diagnostic and response assessment FDG PET‐CT in neurolymphomatosis
por: Bruce, David, et al.
Publicado: (2016)

ITA-IMMUNO-PET: The Role of [18F]FDG PET/CT for Assessing Response to Immunotherapy in Patients with Some Solid Tumors
por: Evangelista, Laura, et al.
Publicado: (2023)

PET/CT in Patients with Breast Cancer Treated with Immunotherapy
por: Vaz, Sofia C., et al.
Publicado: (2023)

Assess PET/MR in diagnosis of disease in comparison with PET/CT
por: Yan, Jianhua, et al.
Publicado: (2015)

F-18 Fluciclovine PET-CT Findings and Pseudoprogression on Immunotherapy
por: Poindexter, Bradley C, et al.
Publicado: (2022)

Serum Tumor Marker Dynamics as Predictive Biomarkers in NSCLC Chemo-Immunotherapy and Mono-Immunotherapy Maintenance: A Registry-Based Descriptive Study
por: Lang, David, et al.
Publicado: (2020)

FDG PET/CT for assessing tumour response to immunotherapy: Report on the EANM symposium on immune modulation and recent review of the literature
por: Aide, Nicolas, et al.
Publicado: (2018)

Heterogeneous Response to Immunotherapy in a Patient with Tonsillar Squamous Cell Carcinoma Assessed by (18)F-FDG PET/CT
por: Niccoli Asabella, Artor, et al.
Publicado: (2021)

Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT
por: Tutino, Francesca, et al.
Publicado: (2023)

FDG-PET/CT in the Monitoring of Lymphoma Immunotherapy Response: Current Status and Future Prospects
por: Al-Ibraheem, Akram, et al.
Publicado: (2023)

Complications of CT-guided transthoracic lung biopsy: A short report on current literature and a case of systemic air embolism
por: Lang, David, et al.
Publicado: (2018)

Impact of [(18)F]FDG PET/CT in the Assessment of Immunotherapy-Induced Arterial Wall Inflammation in Melanoma Patients Receiving Immune Checkpoint Inhibitors
por: Ranjbar, Shaghayegh, et al.
Publicado: (2023)

Assessment of early metabolic progression in melanoma patients under immunotherapy: an (18)F-FDG PET/CT study
por: Sachpekidis, Christos, et al.
Publicado: (2021)

The Impact of PET/CT on Paediatric Oncology
por: Brink, Anita, et al.
Publicado: (2023)

FDG-PET and PET/CT - Part II
por: Takalkar, Amol M, et al.
Publicado: (2008)

Reply to: FDG PET and PET/CT: EANM procedure guideline for tumour PET imaging
por: Boellaard, Ronald, et al.
Publicado: (2010)

[(18)F]FDG PET/CT in the Evaluation of Melanoma Patients Treated with Immunotherapy
por: Mangas Losada, María, et al.
Publicado: (2023)

(18)F‐FDG PET/CT features of immune‐related adverse events and pitfalls following immunotherapy
por: Cherk, Martin H, et al.
Publicado: (2022)

[(18)F]fluoroethylcholine-PET/CT imaging for radiation treatment planning of recurrent and primary prostate cancer with dose escalation to PET/CT-positive lymph nodes
por: Würschmidt, Florian, et al.
Publicado: (2011)

Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer
por: Al-Ibraheem, Akram, et al.
Publicado: (2009)

Local and distant response to intratumoral immunotherapy assessed by immunoPET in mice
por: Meyblum, Louis, et al.
Publicado: (2023)

Aortic valve stenosis—multimodality assessment with PET/CT and PET/MRI
por: Tzolos, Evangelos, et al.
Publicado: (2020)

Choline PET/CT in Multiple Myeloma
por: Mesguich, Charles, et al.
Publicado: (2020)

The Impact of PSMA PET/CT on Modern Prostate Cancer Management and Decision Making—The Urological Perspective
por: Hoffman, Azik, et al.
Publicado: (2023)

FDG-PET/CT for oral focus assessment in head and neck cancer patients
por: Schwaninger, Dominic Raphael, et al.
Publicado: (2022)

FLT PET-CT in evaluation of treatment response
por: Sanghera, Bal, et al.
Publicado: (2014)

The value of FDG PET/CT imaging in outcome prediction and response assessment of lymphoma patients treated with immunotherapy: a meta-analysis and systematic review
por: Kiamanesh, Zahra, et al.
Publicado: (2022)

Assessment of tumour size in PET/CT lung cancer studies: PET- and CT-based methods compared to pathology
por: Cheebsumon, Patsuree, et al.
Publicado: (2012)

The impact of (18) F-FET PET-CT on target definition in image-guided stereotactic radiotherapy in patients with skull base lesions
por: Badakhshi, Harun, et al.
Publicado: (2014)

Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes
por: Emsen, Berivan, et al.
Publicado: (2020)

PET-CT
Publicado: (2011)

Assessment of Image Quality and Lesion Detectability With Digital PET/CT System
por: Delcroix, Olivier, et al.
Publicado: (2021)

Early Evaluation of Immunotherapy Response in Lymphoma Patients by 18F-FDG PET/CT: A Literature Overview
por: Ferrari, Cristina, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_1ouiert6005cqr46p7mjj0l758